VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 134 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,298,000 | +119.6% | 72,464 | +100.0% | 0.02% | -16.7% |
| Q2 2017 | $591,000 | +16.6% | 36,232 | 0.0% | 0.03% | +3.4% |
| Q1 2017 | $507,000 | -15.6% | 36,232 | -49.6% | 0.03% | -45.3% |
| Q1 2016 | $601,000 | -10.2% | 71,849 | 0.0% | 0.05% | +8.2% |
| Q4 2015 | $669,000 | -64.0% | 71,849 | -64.1% | 0.05% | -66.0% |
| Q1 2015 | $1,860,000 | -81.4% | 200,000 | -71.4% | 0.14% | -82.9% |
| Q4 2014 | $10,024,000 | +38.0% | 700,000 | 0.0% | 0.84% | +7.8% |
| Q3 2014 | $7,266,000 | -77.1% | 700,000 | -75.8% | 0.78% | -40.2% |
| Q3 2013 | $31,702,000 | – | 2,895,200 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |